findmyKOL
Clinical trialNCT05705505UnknownPhase 1/PHASE2Interventional

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

SponsorTraws Pharma, Inc.Enrollment60Endometrioid Endometrial Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Oncology Associates, Pc - Hope

    Tucson, Arizona, United States

    Joseph Buscema, MD
    Recruiting
  • Minnesota Oncology Hematology, P.A.

    Minneapolis, Minnesota, United States

    Timothy G Larson, MD
    Recruiting
  • Perlmutter Cancer Center at Nyu Langone Hospital - Long Island

    Mineola, New York, United States

    Bhavana Pothuri, MD
    Recruiting
  • Nyu Langone

    New York, New York, United States

    Bhavana Pothuri, MD
    Recruiting
  • Willamette Valley Cancer Institute and Research Center

    Eugene, Oregon, United States

    Charles K Anderson, MD
    Recruiting
  • Greenville Health System, Institute for Oncology Clinical Research

    Greenville, South Carolina, United States

    W. Jeff Edenfield, MD
    Recruiting
  • Texas Oncology-Baylor Charles A. Sammons Cancer Center

    Dallas, Texas, United States

    Noelle G Cloven, MD
    Recruiting
  • Texas Oncology - Fort Worth Cancer Center

    Fort Worth, Texas, United States

    Noelle G Cloven, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Mar 2023
Primary completion
31 Jan 2026
Completion
28 Feb 2026
Last update posted
12 Dec 2023
Registered enrollment
60
Registry id
NCT05705505
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.